Markets:

Overview

News

Currencies

International

Treasuries

Dare Bioscience, Inc. - Common Stock (NQ:DARE)

0.8153 +0.0053 (+0.65%)

Streaming Delayed Price Updated: 11:55 AM EDT, Aug 21, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Dare Bioscience, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >

3 Women's Health Stocks Are Soaring Following Roe v. Wade Ruling ↗

June 27, 2022

Three days after the U.S. Supreme Court struck down Roe v. Wade in one of the most potentially impactful rulings of the last century, a handful of women's health stocks are on the move on Monday in...

Via Benzinga

The Daily Biotech Pulse: Bristol Myers, BridgeBio Ink Oncology Pact, FDA Nod For Lava Therapeutics Blood Cancer Study And More ↗

May 12, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Dare Bioscience: Q1 Earnings Insights ↗

May 12, 2022

Dare Bioscience (NASDAQ:DARE) reported its Q1 earnings results on Thursday, May 12, 2022 at 06:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Earnings Preview: Dare Bioscience ↗

May 11, 2022

Dare Bioscience (NASDAQ:DARE) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to know before the announcement. Analysts estimate that Dare...

Via Benzinga

Recap: Dare Bioscience Q4 Earnings ↗

March 31, 2022

Dare Bioscience (NASDAQ:DARE) reported its Q4 earnings results on Thursday, March 31, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight ↗

August 08, 2021

Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in,...

Via Benzinga

Organon Inks Licensing Pact For Daré Bioscience's Bacterial Vaginosis Treatment ↗

March 31, 2022

Organon & Co (NYSE: OGN)

Via Benzinga

Organon Enters into Global License Agreement to Commercialize Daré Bioscience’s XACIATO™ (clindamycin phosphate vaginal gel, 2%), FDA-Approved Treatment for Females 12 and Older with Bacterial Vaginosis (BV)

March 31, 2022

From Organon & Co.

Via Business Wire

Earnings Preview: Dare Bioscience ↗

March 30, 2022

Dare Bioscience (NASDAQ:DARE) is set to give its latest quarterly earnings report on Thursday, 2022-03-31. Here's what investors need to know before the announcement. Analysts estimate that Dare...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

December 29, 2021

Gainers Orchard Therapeutics (NASDAQ:ORTX) stock moved upwards by 12.6% to $1.34 during Wednesday's pre-market session. The market value of their outstanding shares is...

Via Benzinga

Earnings Scheduled For March 31, 2022 ↗

March 31, 2022

Companies Reporting Before The Bell • Trevena (NASDAQ:TRVN) is likely to report earnings for its fourth quarter.

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

December 27, 2021

Gainers OptiNose (NASDAQ:OPTN) shares mov...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

December 09, 2021

Gainers Ensysce Biosciences (NASDAQ:ENSC) stock increased by 74.49% to $5.2 during Thursday's pre-market session. The market value of their outstanding shares is at $...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

December 09, 2021

Good morning, trader! It's time to kick off another busy day of trading with the biggest pre-market stock movers for Thursday!

Via InvestorPlace

35 Stocks Moving In Wednesday's Mid-Day Session ↗

December 08, 2021

Gainers Insignia Systems, Inc. (NASDAQ: ISIG) shares jumped 79% to $18.63. Insignia Systems recently announced the commencement of a formal process to explore strategic options...

Via Benzinga

Penny Stocks to Watch: What’s Going on With ZOM, DARE, PSFE, EFOI and AUUD Today? ↗

December 08, 2021

Penny stocks are still a hot topic among retail traders and we're covering some of the top ones to watch Wednesday that are on the move.

Via InvestorPlace

BZ Chart Of The Day: Dare Bioscience ↗

December 08, 2021

If markets have memories, shares of Daré Bioscience, Inc. (NASDAQ: DARE) may be in trouble. The stock has run into a resistance level. Resistance is a large group of...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

December 08, 2021

Gainers Lexaria Bioscience (NASDAQ:LEXX) shares increased by 30.28% to $6.41 during Wednesday's pre-market session. The company's market cap stands at $36.7...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

December 08, 2021

We've reached the halfway point of the week and there's no slowing down as we dive into the biggest pre-market stock movers for Wednesday!

Via InvestorPlace

22 Stocks Moving in Wednesday's Pre-Market Session ↗

December 08, 2021

Gainers Daré Bioscience, Inc. (NASDAQ: DARE) rose 45.2% to $3.08 in pre-market trading after the company reported the FDA approval of XACIATO Vaginal Gel as a treatment...

Via Benzinga

Daré Bioscience's One-Time Bacterial Vaginosis Treatment Scores FDA Approval ↗

December 07, 2021

The FDA has approved Daré Bioscience Inc (NASDAQ: DARE) Xaciato (DARE-BV1) to treat bacterial vaginosis. Xaciato is a thermosetting bioadhesive...

Via Benzinga

The Daily Biotech Pulse: Acadia Jumps On Data, vTv Shelves Psoriasis Study, More Setbacks For Merck's HIV Program, Decision Day For Daré ↗

December 07, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Acadia Announces Positive Phase 3 Data For Trofinetide In Rett Syndrome...

Via Benzinga

The Week Ahead In Biotech (Dec. 6-Dec. 11): Daré FDA Decision, Adcom Tryst For Reata, Multiple Conference Presentations And More ↗

December 06, 2021

The omicron variant concerns were front and center in the markets in the week ended Dec. 3, and biotech stocks did not escape the brunt of selling in the wake of the negative...

Via Benzinga

Attention Biotech Investors: Mark Your Calendar For December PDUFA Dates ↗

December 02, 2021

A majority of verdicts handed down by the FDA in November were positive. Three new molecular entities were approved during the month, taking the total number of NME approvals for...

Via Benzinga

The Daily Biotech Pulse: Valneva Inks COVID-19 Vaccine Supply Contract In Europe, I-Mab Spikes On China Deal, DermTech Sinks On Guidance ↗

November 10, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus MorphoSys COO To Leave To Pursue Other Opportunities MorphoSys AG (NASDAQ:...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

September 28, 2021

Gainers Geovax Labs (NASDAQ:GOVX) shares...

Via Benzinga

Daré Bioscience Stock Is Trading Higher As Bacterial Vaginosis Candidate Secures FDA Priority Review ↗

August 09, 2021

The FDA has accepted for review Daré Bioscience Inc's (NASDAQ: DARE) marketing application for DARE-BV1 for bacterial vaginosis. Under the priority...

Via Benzinga

The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma ↗

August 12, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 11) Adagio Therapeutics, Inc. (...

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

August 09, 2021

Gainers Windtree Therapeutics (NASDAQ:WINT) stock rose 30.38% to $2.36 during Monday's pre-market session. The company's market cap stands at $61.9 million. The...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

July 13, 2021

Gainers SCWorx (NASDAQ:WORX) stock increased by 38.34% to $3.68 during Tuesday's pre-market session. The company's market cap stands at $36.9 million. PLx Pharma (...

Via Benzinga

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.